Idarubicin hydrochloride Injection 10 mg in 10 mL (2)

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

idarubicin hydrochloride, Quantity: 1 mg/mL

Disponível em:

Pfizer (Perth) Pty Ltd

Forma farmacêutica:

Injection, solution

Composição:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Via de administração:

Intravenous Infusion

Unidades em pacote:

1 x 10 mL

Tipo de prescrição:

(S1) This Schedule is intentionally blank

Indicações terapêuticas:

Idamycin PFS Injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults. This includes the French-American-British (FAB) classifications M1 through M7.

Resumo do produto:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution.; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Listed (Export Only)

Data de autorização:

2019-05-03